AJDRAJNR - American Journal of Neuroradiology

Published ahead of print on November 7, 2007
doi: 10.3174/ajnr.A0818
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prabhakaran, S.
Right arrow Articles by Lopes, D.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prabhakaran, S.
Right arrow Articles by Lopes, D.K.

Prevalence and Risk Factors for Aspirin and Clopidogrel Resistance in Cerebrovascular Stenting

S. Prabhakarana, K.R Wellsa, V.H. Leea, C.A. Flahertya and D.K. Lopesa

a From the Rush University Medical Center, Department of Neurological Sciences, Chicago, Ill


Figure 1
View larger version (18K):
[in this window]
[in a new window]

  		Fig 1. A, Scatterplot of aspirin reaction units (x-axis) versus aspirin dose (y-axis). There is a strong inverse correlation (P = .01). Gray area indicates aspirin resistance. B, Scatterplot of platelet inhibition (x-axis) versus clopidogrel dose (y-axis). There is no correlation (P = .64). Gray area indicates clopidogrel resistance.





Copyright © 2009 by the American Society of Neuroradiology. Print ISSN: 0195-6108 Online ISSN: 1936-959X